{"id":"W4353014868","doi":"10.1038/s41408-023-00804-y","title":"Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy","year":2023,"lang":"en","type":"review","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Chugai Pharmaceutical; Seagen; bluebird bio; Regeneron Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; GlaxoSmithKline","keywords":"Lenalidomide; Medicine; Daratumumab; Multiple myeloma; Intensive care medicine; Clinical trial; Bortezomib; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003604755,0.0006118395,0.00275516,0.0008492319,0.0001424963,0.0001448031,0.0004988873,0.0003833286,0.00002864277],"category_scores_gemma":[0.002863365,0.0004289714,0.00140672,0.00045914,0.00008962937,0.0002001044,0.00006895098,0.001481779,0.00000838586],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000616163,"about_ca_system_score_gemma":0.00487489,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008283874,"about_ca_topic_score_gemma":0.001178139,"domain_scores_codex":[0.9946908,0.0004915609,0.00232096,0.0007903019,0.0007320032,0.0009743372],"domain_scores_gemma":[0.9892424,0.008736896,0.0008251134,0.0004978161,0.000372445,0.00032534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002179298,0.0009812287,0.003928,0.01084464,0.0006646424,0.0003513904,0.00007515578,0.00002848141,9.100099e-7,0.00001053666,0.0000320117,0.9809037],"study_design_scores_gemma":[0.05585169,0.005631359,0.0293652,0.6409276,0.002113986,0.0002678947,0.0002564376,0.0014207,0.00001475278,0.001092684,0.2617565,0.001301243],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004328791,0.9887267,0.0004943975,0.0002136309,0.000947942,0.005093975,0.0001564619,0.00003476759,0.000003324598],"genre_scores_gemma":[0.007573978,0.9852162,0.00209846,0.00001387701,0.001371521,0.003528339,0.00004436664,0.0001413424,0.00001190172],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9796025,"threshold_uncertainty_score":0.9998162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5237619651572638,"score_gpt":0.5617298454699142,"score_spread":0.03796788031265041,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}